Site Search
Fund Objective

The EGShares Health Care GEMS exchange-traded fund (ETF) seeks to achieve its investment objective of total return by investing in the constituent securities of the Dow Jones Emerging Markets Health Care Titans 30 Index. The index is created to represent 30 of the largest emerging market companies in the Health Care Industry as defined by the Industry Classification Benchmark (ICB). Stocks are selected to the index based on rankings by float-adjusted market capitalization, revenue and net profit.

Key Statistics
(As of 12/31/11)
ETF Ticker (NYSE):
HGEM
Bloomberg Index Ticker:
DJEHKT
Inception Date
6/23/2011
Net Expenses*
0.85%
Holdings
30
Average Market Cap
$3.96B
Median Market Cap
$3.84B
Index Dividend Yield
11.0x
Price/Book Ratio
2.6x
Index Dividend Yield
1.41x

Country Weights

(As of 12/31/11)
Country
Weights
India
37.8%
South Africa
24.4
China
17.4
Hungary
5.1
Indonesia
3.9
Thailand
3.1
Russia
2.7
Mexico
2.3
Malaysia
1.5
Chile
1.4

Industry Weights

(As of 12/31/11)
Industry
Weights
Pharmaceuticals & Biotechnology
71.4%
Health Care Equipment & Services
28.6

Top 10 Holdings

(As of 12/31/11)
Company
Weights
Aspen Pharmacare Holdings Ltd
10.5%
Dr Reddy's Laboratories Ltd
8.8
Sun Pharmaceutical Industries Ltd
8.7
Cipla Ltd/India
7.4
Mindray Medical International Ltd
5.7
Sinopharm Group Co Ltd
4.5
Netcare Ltd
4.5
Richter Gedeon Nyrt
4.4
Mediclinic International Ltd
4.1
Kalbe Farma Tbk PT
3.9

Performance

(As of 12/31/11)
   1-Month (%) 3-Month (%) Year-to-Date (%) 1-Year (%) Since
Inception (%)**
  Total Returns
(Net Asset Value)		 -3.25 -2.04 NA NA -17.76
  Total Returns
(Market Price)		 -6.07 -0.81 NA NA -18.56
  Dow Jones Emerging Markets Health Care Titans 30 Index -2.96 -1.95 -20.92 -20.92 -17.28

Performance data quoted represents past performance. Past performance does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance data may be higher or lower than actual data quoted.

This Fund will concentrate its investments in issuers of one or more particular industries to the same extent that its Underlying Index is so concentrated and to the extent permitted by applicable regulatory guidance. Concentration risk results from maintaining exposure to issuers conducting business in a specific industry.

Market price returns are based on the midpoint of the bid/ask spread at 4 p.m. ET and do not represent the returns an investor would receive if shares were traded at other times.

*Gross expenses of 1.20% are reimbursed to keep from exceeding 0.85% of net assets. This agreement will remain in effect and will be contractually binding at least until July 29, 2012.

**HGEM inception date is 6/23/2011